pharmacontrol corp said acquired private formulations inc from for six mln dlrs cash 550 000 dlr promissory and warrants buy 200 000 pharmacontrol common shares pharmacontrol said purchase price was financed along with mln dlrs working capital through secured institutional financing company said betweenm 550 000 dlrs and 550 000 dlrs principal amount revco plus accrued interest payable june balance payable over three years pharmacontrol said expects payment due revco from proceeds proposed offering units consisting convertible subordinated debenturers and common stock currently file with securities and exchange commission upon closing public offering company said expects secured institutional financing increase total mln dlrs private formulations primarily engaged manufacture and distribution vitamins and private label over counter pharmaceutical products reuter 